Authid Inc. current report, 15 February 2024

Business Context and Reporting Period

This Form 8-K Current Report was filed by authID Inc. (Nasdaq: AUID) on February 22, 2024, covering events occurring on February 15, 2024. The company is an emerging growth company incorporated in Delaware.

Key Financial Metrics

This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on corporate governance changes.

Material Changes

  • Departure of Chairman and Director: Joe Trelin resigned as Chairman and Director effective February 15, 2024. The Board accepted the resignation on February 20, 2024.
  • Compensatory Arrangement: Upon resignation, the Board agreed to vest the unvested portion of an option granted to Mr. Trelin on June 28, 2023, totaling 6,511 shares.
  • Board Composition: Following the resignation, the Board consists of six directors, three of whom are Independent Directors. This composition currently falls short of the Nasdaq requirement for a majority of Independent Directors.
  • Audit Committee Appointment: Michael Thompson was appointed to the Audit Committee on February 20, 2024, to ensure compliance with Nasdaq Rule 5605(c)(2)(A).

Outlook, Risks, and Contingencies

Nasdaq Compliance Risk: The company is currently in discussions with candidates to appoint an additional Independent Director to restore the required majority. No agreement has been reached as of the filing date.

Cure Period: Under Nasdaq Rule 5605(b)(1)(A), the company has a cure period to restore the majority of Independent Directors. This period expires on the earlier of the date of the next Annual Meeting or one year from the date of the vacancy, subject to a minimum period of 180 days from the vacancy date.

Investor Verification Checklist

  • Verify the timeline for appointing a new Independent Director to meet the 180-day minimum cure period.
  • Confirm the impact of the 6,511 share vesting on the company's outstanding share count and dilution.
  • Monitor future filings for the appointment of a replacement Chairman or Independent Director.
  • Check for any subsequent 8-K filings regarding the status of the Board's independence compliance.